[1]
Mardining Raras, T.Y., Fahrinda, A., Yuliati, Y., Nurhidayati, D.Y., Sujuti, H. and Prawiro, S.R. 2022. IMMUNE RESPONSE UPON THE ADMINISTRATION OF RECOMBINANT PROTEIN ANTIBODIES Ag-38 KDa Mycobacterium tuberculosis AND RIFAMPICIN EX-VIVO. African Journal of Infectious Diseases (AJID). 16, 2 (May 2022), 71–79. DOI:https://doi.org/10.21010/Ajid v16i2.8.